Filana Therapeutics, Inc. (FLNA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$6.42M

Year ended 2020-12-31

2009-12-31 EBITDA (USD) 2020-12-31

Period ended	EBITDA	Change YoY	Source filing
2020-12-31	-$6.42M	n/m	2023-02-28, From 2020-01-01
2019-12-31	-$4.90M	n/a	2021-03-23, From 2019-01-01
No annual figure between 2012-12-31 and 2019-12-31.
2012-12-31	-$3.77M	n/m	2015-02-18, From 2012-01-01
2011-12-31	-$3.35M	n/m	2014-02-05, From 2011-01-01
2010-12-31	-$13.47M	n/m	2013-02-08, From 2010-01-01
2009-12-31	-$6.50M	n/a	2012-02-09, From 2009-01-01